Park Medi World Limited has released the audio recording of its earnings conference call, which was held on August 04, 2026. The discussion focused on the company’s unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, providing investors with insights into the latest performance metrics and operational updates.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The audio file is hosted on the company’s official website under the investor relations section, ensuring accessibility for shareholders and market participants seeking detailed commentary on the quarterly figures.

Key Details

Abhishek Kapoor, Company Secretary & Compliance Officer, signed the disclosure notice submitted to both the BSE Limited and the National Stock Exchange of India Limited. The filing confirms that the recording is available for public access at the designated URL on the Park Medi World website.

What the Numbers Show

While the specific financial metrics such as net profit, revenue, or EBITDA were not detailed in this specific disclosure notice, the availability of the earnings call audio allows stakeholders to hear management’s direct commentary on the drivers behind the Q1FY27 performance. Investors are advised to listen to the recording for a comprehensive understanding of the strategic initiatives and financial health of the hospital group during the period ending June 30, 2026.

Park Medi World reported a consolidated net profit of ₹885.93 million for the quarter ended June 30, 2026, marking a 34% year-on-year increase from ₹655.06 million in Q1FY25. The growth was driven by a 19% rise in revenue from operations to ₹4,757.09 million, supported by the integration of new hospital capacities and operational efficiencies across its network of 17 hospitals and 4,290 beds.

The Board of Directors approved the financial results on August 03, 2026, pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory auditors Agiwal & Associates issued an unmodified limited review report on both standalone and consolidated statements. The company also disclosed the acquisition of Mehar Hospital-Zirakpur from Mehar Mediserve LLP for an all-cash consideration of approximately ₹1,070 million, aimed at deepening its presence in the Tricity cluster.

Financial Performance

Consolidated revenue from operations grew to ₹4,757.09 million in Q1FY27, compared to ₹3,988.45 million in the prior year period. Profit before tax stood at ₹1,050.84 million, up from ₹818.99 million. EBITDA increased by 20% to ₹1,260.88 million from ₹1,049.31 million in Q1FY25. Total comprehensive income attributable to owners of the parent was ₹819.38 million. Basic earnings per share (EPS) increased to ₹2.05 from ₹1.70 in the corresponding quarter last year.

Standalone results showed more modest growth, with net profit after tax at ₹10.84 million versus ₹48.97 million in Q1FY25. Standalone revenue from operations rose 46% YoY to ₹335.32 million from ₹229.69 million, though other income declined significantly from ₹82.69 million in Q4FY25 to ₹46.68 million in Q1FY26.

Strategic Acquisitions and Expansion

The company executed a definitive agreement to acquire 100% stake in Mehar Mediserve LLP, which operates Mehar Hospital-Zirakpur, a 150+ bed multi-super speciality facility. The transaction is valued at ₹1,070 million and is expected to be commissioned under the Park brand by November 2026. This acquisition complements existing facilities in Mohali, Panchkula, Patiala, and Bathinda, reinforcing the group’s cluster-based strategy in Punjab.

As a subsequent event, Park Medi World acquired an 80% shareholding in V3 Healthcare Private Limited on July 31, 2026, for approximately ₹1,770 million. V3 operates The Medicity Hospital-Rudrapur, a 330-bed facility in Uttarakhand, which launched on August 2, 2026. The remaining 20% stake will be acquired by April 30, 2030.

Capacity Additions and IPO Utilization

The group has added approximately 1,500 beds in the past twelve months, representing a 46% capacity expansion. Key launches include a 350-bed hospital in Panchkula (April 2026) and the upcoming expansion of Park Hospital in Palam Vihar, Gurugram, branded as "Park Hospital Platinum," adding 100 beds by November 2026 at a cost of ₹250 million funded from internal accruals. RGS Healthcare Limited’s Mohali unit is also expanding from 350 to 500 beds at a cost of ₹400 million.

Regarding IPO proceeds, ₹6,484.45 million out of ₹7,132.77 million planned for specific objects has been utilized as of June 30, 2026. The remaining ₹648.32 million is pending utilization for capital expenditure on new hospitals and medical equipment. The Board proposed a variation in the objects of IPO proceeds, subject to shareholder approval via postal ballot.